Pacific Biosciences Of California PACB
NASDAQ PACB
$2.51 +0.14 (+5.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pacific Biosciences Of California (PACB) Goodwill impairment charges (2024)

Updated

Pacific Biosciences Of California (PACB) posted Goodwill impairment charges of $93.2 million for Q2 2024.

Analysis

Pacific Biosciences Of California (PACB) Goodwill impairment charges (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Pacific Biosciences Of California 736.62 Mn -354.38 Mn 12.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 93.20 Mn
API Access

Pacific Biosciences Of California Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=PACB&period=max&api_key=YOUR_API_KEY